Brief: Hofseth Biocare Q4 operating revenue up at NOK 26.7 million, operating loss narrows
Feb 18 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Q4 EBIT loss 16.3 million Norwegian crowns versus loss
28.2 million crowns year ago
* Q4 operating revenue 26.7 million crowns versus 9.1
million crowns year ago
Source text for Eikon: ID:nDjc8Y40Gc
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48586983920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering